| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |